# Oruka Therapeutics, Inc.: Form 8-K, filed Jun 4, 2026

- Company: [Oruka Therapeutics, Inc.](/companies/orka.md) (CIK 907654)
- Form: 8-K
- Filed: 2026-06-04
- Accepted by EDGAR: Jun 4, 2026, 16:15 ET
- Period: 2026-06-02
- Accession: 0001213900-26-065294
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/907654/000121390026065294/ea0293648-8k_oruka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/907654/000121390026065294/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/907654/000121390026065294/ea0293648-8k_oruka.htm

Filed Jun 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-065294. Last ingested by Listed: Nov 2, 2026, 20:24 ET. No prices; not investment advice.